Profile
Andrew Muratore currently works at Trillium Therapeutics ULC, as Director & Vice President from 2021.
Andrew Muratore active positions
| Companies | Position | Start |
|---|---|---|
| TRILLIUM THERAPEUTICS | Director/Board Member | 2021-11-16 |
Experiences
Positions held
Connections
16
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
- Stock Market
- Insiders
- Andrew Muratore
